Who owns PHIO PHARMACEUTICALS CORP?
- Ticker: PHIO
- CUSIP Number: 71880w501
Tip: Access positions for across all investors
Analyze quarterly positions in Phio Pharmaceuticals Corp with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Phio Pharmaceuticals Corp stock
Who bought or sold PHIO PHARMACEUTICALS CORP this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jane Street | 118k | $121k | -1% | Jun 2026 |
|
| Geode Capital Management | 115k | $117k | -22% | Jun 2026 |
|
| Vanguard Capital Management | 94k | $97k | 18% | Jun 2026 |
|
| Nomura Asset Management International | 50k | $51k | 100% | Jun 2026 |
|
| Cetera Investment Advisers | 48k | $49k | 6% | Jun 2026 |
|
| Citadel Advisors | 47k | $48k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 38k | $39k | 0% | Jun 2026 |
|
| Northern Trust | 28k | $29k | 17% | Jun 2026 |
|
| Two Sigma Investments | 22k | $22k | -34% | Jun 2026 |
|
| XTX Topco | 19k | $19k | -26% | Jun 2026 |
|
| Hrt Financial | 13k | $13k | -62% | Jun 2026 |
|
| Bridgeway Capital Management | 12k | $12k | 100% | Jun 2026 |
|
| Captrust Financial Advisors | 10k | $10k | 0% | Jun 2026 |
|
| Tower Research Capital | 6.2k | $6.4k | -19% | Jun 2026 |
|
| Morgan Stanley | 6.0k | $7.3k | 0% | Mar 2026 |
|
| UBS Group | 5.4k | $5.5k | -80% | Jun 2026 |
|
| Advisor Group Holdings | 2.0k | $2.1k | 0% | Jun 2026 |
|
| Spire Wealth Management | 2.0k | $2.1k | 0% | Jun 2026 |
|
| SBI Securities | 1.2k | $1.3k | 2% | Jun 2026 |
|
| Citigroup | 1.0k | $1.3k | 100% | Mar 2026 |
|
| Barclays | 231.00 | $237.006000 | 100% | Jun 2026 |
|
| Assetmark | 110.00 | $113.003000 | 0% | Jun 2026 |
|
| Activest Wealth Management | 9.00 | $9.000000 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 6.00 | $6.000000 | 100% | Jun 2026 |
|
Who sold out of Phio Pharmaceuticals Corp?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Scientech Research | Mar 2026 | 30k | $37k |
| GSA Capital Partners | Mar 2026 | 20k | $24k |
| Two Sigma Securities | Mar 2026 | 15k | $19k |
| Nbc Securities | Mar 2026 | 1.1k | $1.3k |